PPL
60
3
BAC
54
3
AN
49
3
IRM
75
2
BIIB
42
-2
DE
49
9
VLO
30
2
AVB
54
4
RSG
70
2
MMM
47
2
SRCL
34
3
FIS
55
2
BAX
44
-3
VNO
59
3
GE
67
2
URBN
50
2
ADT
41
-2
V
62
10
GLW
55
2
WFC
82
2
PPL
60
3
BAC
54
3
AN
49
3
IRM
75
2
BIIB
42
-2
DE
49
9
VLO
30
2
AVB
54
4
RSG
70
2
MMM
47
2
SRCL
34
3
FIS
55
2
BAX
44
-3
VNO
59
3
GE
67
2
URBN
50
2
ADT
41
-2
V
62
10
GLW
55
2
WFC
82
2
Financhill
Back

Apellis Pharmaceuticals Vs. Blueprint Medicines Industry Stock Comparison

Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
27.90
Seasonality Move:
25.98%
Sell
37

BPMC
Blueprint Medicines

Last Price:
85.97
Seasonality Move:
8.08%
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $27.95. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $89.33. The Score for BPMC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $27.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $89.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.21 Sell
Relative Strength Index (14 RSI): 34 Sell
Chaikin Money Flow: -61032 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.9 - 34.22) Sell
Bollinger Bands (100): (32.37 - 41.13) Sell

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.77 Sell
Relative Strength Index (14 RSI): 48.78 Sell
Chaikin Money Flow: -260874 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (87.01 - 90.91) Buy
Bollinger Bands (100): (89.35 - 109.47) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.35 Buy
20-day SMA: 29.1 Sell
50-day SMA: 34.42 Sell
200-day SMA: 47.21 Sell
8-day EMA: 27.73 Buy
20-day EMA: 29.48 Sell
50-day EMA: 33.11 Sell
200-day EMA: 42.85 Sell

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 88.42 Buy
20-day SMA: 89.45 Sell
50-day SMA: 90.66 Sell
200-day SMA: 94.8 Sell
8-day EMA: 88.81 Buy
20-day EMA: 89.2 Buy
50-day EMA: 92.08 Sell
200-day EMA: 90.99 Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.30 per share, and an increase next year of $1.30 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.61 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.02 per share, and an increase next year of $0.44 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):